An in silico high-throughput screen identifies potential selective inhibitors for the non-receptor tyrosine kinase Pyk2
Tomer Meirson, Abraham O Samson, Hava Gil-Henn Faculty of Medicine in the Galilee, Bar-Ilan University, Safed, Israel Abstract: The non-receptor tyrosine kinase proline-rich tyrosine kinase 2 (Pyk2) is a critical mediator of signaling from cell surface growth factor and adhesion receptors to cell mi...
Saved in:
Main Authors: | Meirson T (Author), Samson AO (Author), Gil-Henn H (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2017-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
In-Silico Screening of Novel Synthesized Thienopyrimidines Targeting Fms Related Receptor Tyrosine Kinase-3 and Their In-Vitro Biological Evaluation
by: Elshaymaa I. Elmongy, et al.
Published: (2022) -
Molecular profiling of TAM tyrosine kinase receptors and ligands in endometrial carcinoma: An in silico-study
by: Dilara Fatma Akin, et al.
Published: (2023) -
Model-Based Biomarker Selection for Dose Individualization of Tyrosine-Kinase Inhibitors
by: Maddalena Centanni, et al.
Published: (2020) -
Virtual screening for potential inhibitors of Mcl-1 conformations sampled by normal modes, molecular dynamics, and nuclear magnetic resonance
by: Glantz-Gashai Y, et al.
Published: (2017) -
Novel Receptor Tyrosine Kinase Pathway Inhibitors for Targeted Radionuclide Therapy of Glioblastoma
by: Julie Bolcaen, et al.
Published: (2021)